Anuh Pharma: To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of…
Anuh Pharma (ANUHPHR) filed a disclosure titled "To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion". The company is valued at about ₹822 crore.
What happened
Anuh Pharma (ANUHPHR) filed a disclosure with the exchanges on 13 October 2026 at 06:37 PM titled "To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion".
Company snapshot
Anuh Pharma is a micro-cap company, with a market value of about ₹822 crore.
The stock last traded at ₹82.02, against a 52-week range of ₹67–₹99.5 (17.6% below the high).
Before this filing the shares had moved −15.2% over the month and +4.1% over three months. Average daily turnover over the last 20 sessions was about ₹1.06 crore.
Promoters held 71.80% at the end of Q1 FY27. Foreign institutions owned 0.01% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 186 | 8.3 | 1.66 |
| Q2 FY26 | 372 | 15.9 | 1.59 |
| Q3 FY26 | 197 | 13.5 | 1.34 |
| Q4 FY26 | 202 | 11.7 | 1.17 |
| Q1 FY27 | 194 | 11.4 | 1.14 |
What history shows
BCEIE has no earlier similar filing from this company on record since May 2026.
Market-wide, 105 similar filings with an impact score of 50 or more saw an average next-day move of +0.6%, with 45% rising.
Past reactions describe what happened before; they are not a forecast.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.